My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Breast cancer in men.

    Giordano SH, Buzdar AU, Hortobagyi GN.

    Ann Intern Med. 2002 Oct 15;137(8):678-87. Review.PMID: 12379069 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Male breast cancer: history, epidemiology, genetic and histopathology]

    Leinung S, Horn LC, Backe J.

    Zentralbl Chir. 2007 Oct;132(5):379-85. Review. German. PMID: 17907078 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.PMID: 16959170 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Carcinoma of the male breast.

    Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA.

    Ann Intern Med. 1992 Nov 1;117(9):771-7. Review.PMID: 1416579 [PubMed - indexed for MEDLINE]Related articles

    6.

    Summaries for patients. Breast cancer in men.

    [No authors listed]

    Ann Intern Med. 2002 Oct 15;137(8):I63. No abstract available. PMID: 12379091 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Epidemiology of male breast cancer.

    Weiss JR, Moysich KB, Swede H.

    Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):20-6. Review.PMID: 15668471 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.

    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.

    Cancer Res. 2003 Jan 15;63(2):342-7.PMID: 12543786 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Male breast carcinoma.

    Meguerditchian AN, Falardeau M, Martin G.

    Can J Surg. 2002 Aug;45(4):296-302. Review.PMID: 12174988 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Breast carcinoma in men: a population-based study.

    Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN.

    Cancer. 2004 Jul 1;101(1):51-7.PMID: 15221988 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

    BMC Cancer. 2007 Apr 12;7:63.PMID: 17430582 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Clinicopathological study of male breast carcinoma: 24 years of experience.

    Shah P, Robbani I, Shah O.

    Ann Saudi Med. 2009 Jul-Aug;29(4):288-93.PMID: 19584580 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Male breast cancer in the veterans affairs population: a comparative analysis.

    Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R.

    Cancer. 2007 Apr 15;109(8):1471-7.PMID: 17342768 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Adjuvant systemic therapy for male breast carcinoma.

    Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN.

    Cancer. 2005 Dec 1;104(11):2359-64.PMID: 16270318 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.

    Kwiatkowska E, Teresiak M, Filas V, Karczewska A, Breborowicz D, Mackiewicz A.

    Clin Cancer Res. 2003 Oct 1;9(12):4452-9.PMID: 14555518 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States.

    Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL.

    Clin Breast Cancer. 2007 Jun;7(8):627-33.PMID: 17592676 [PubMed - indexed for MEDLINE]Related articles

    17.

    The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.

    Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, Venturo I, Botti C, Jager E, Santoni A, Natali PG, Nisticò P.

    Clin Cancer Res. 2006 Mar 1;12(5):1470-8.PMID: 16533770 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Racial disparities in treatment and survival of male breast cancer.

    Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL.

    J Clin Oncol. 2007 Mar 20;25(9):1089-98.PMID: 17369572 [PubMed - indexed for MEDLINE]Related articles

    19.

    Factors predictive of response to hormone therapy in breast cancer.

    Rastelli F, Crispino S.

    Tumori. 2008 May-Jun;94(3):370-83. Review.PMID: 18705406 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.

    Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN.

    J Clin Oncol. 2006 May 1;24(13):2113-22. Review.PMID: 16648513 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity